{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:24Z","timestamp":1790727924294,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.phrs.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T16:45:23Z","timestamp":1491842723000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management"],"prefix":"10.1016","volume":"120","author":[{"given":"T.P.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Korolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.04.008_bib0005","series-title":"Heart disease and stroke statistics \u2013 update","year":"2016"},{"key":"10.1016\/j.phrs.2017.04.008_bib0010","doi-asserted-by":"crossref","first-page":"1307S","DOI":"10.1093\/ajcn\/72.5.1307s","article-title":"For the pathobiological determinants of atherosclerosis in youth (PDAY) research group: origin of atherosclerosis in childhood and adolescence","volume":"72","author":"McGill","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of Early Lesions in Children (FELIC) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.04.008_bib0020","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.ATV.13.9.1291","article-title":"Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study","volume":"13","author":"Pathological Determinants of Atherosclerotic in Youth (PDAY) Research Group","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.phrs.2017.04.008_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(95)05525-2","article-title":"Histological features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: Bogalusa Heart Study","volume":"116","author":"Tracy","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2017.04.008_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1058-9813(03)00048-1","article-title":"Cholesterol as a risk factor for early atherosclerosis: the Bogalusa Heart Study","volume":"17","author":"Berenson","year":"2003","journal-title":"Prog. Pediatr. Cardiol."},{"issue":"9716","key":"10.1016\/j.phrs.2017.04.008_bib0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2017.04.008_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2042098612439884","article-title":"Safety of statins: an update","volume":"3","author":"Hu","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"issue":"5","key":"10.1016\/j.phrs.2017.04.008_bib0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1194\/jlr.M011122","article-title":"Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport","volume":"52","author":"Malik","year":"2011","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1139\/y11-118","article-title":"Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407","volume":"90","author":"Korolenko","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.04.008_bib0055","series-title":"Handbook of Macrophages: Life Cycle, Functions and Diseases","first-page":"249","article-title":"Macrophage stimulation and \u03b2-D-glucans as biological response modifiers: the role in experimental tumor development","author":"Korolenko","year":"2012"},{"issue":"1","key":"10.1016\/j.phrs.2017.04.008_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","article-title":"Cholesterol-lowering effects of dietary fiber: a meta-analysis","volume":"69","author":"Brown","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0065","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3945\/ajcn.114.086108","article-title":"Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials","volume":"100","author":"Whitehead","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1258\/ebm.2012.012091","article-title":"Role of macrophage activation in the lipid metabolism of postprandial triacylglycerol-rich lipoproteins","volume":"238","author":"Napolitano","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"10.1016\/j.phrs.2017.04.008_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1194\/jlr.R400011-JLR200","article-title":"Thematic review series: the immune system and atherogenesis: recent insights into the biology of macrophage scavenger receptors","volume":"46","author":"Greaves","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2017.04.008_bib0080","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.108.830661","article-title":"Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density-lipoprotein receptor-deficient mice","volume":"119","author":"Matthijsen","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2017.04.008_bib0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/bchm3.1992.373.2.573","article-title":"Endocytosis by liver cells during suppression of intralysosomal proteolysis","volume":"373","author":"Korolenko","year":"1992","journal-title":"Biol. Chem. Hoppe Seyler"},{"issue":"5\u20136","key":"10.1016\/j.phrs.2017.04.008_bib0095","first-page":"261","article-title":"The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy","volume":"24","author":"Svechnikova","year":"1998","journal-title":"Drugs Exp. Clin. Res."},{"issue":"12","key":"10.1016\/j.phrs.2017.04.008_bib0100","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/jphp.12633","article-title":"A comparative study of the hypolipidaemic effects of a new polysaccharide, mannan Candida albicans serotype A, and atorvastatin in mice with poloxamer 407-induced hyperlipidaemia","volume":"68","author":"Korolenko","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2017.04.008_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosissup.2008.05.007","article-title":"Novel aspects of postprandial lipemia in relation to atherosclerosis","volume":"9","author":"Alipour","year":"2008","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phrs.2017.04.008_bib0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(79)91777-X","article-title":"Treatment of diabetes with glucomannan","volume":"1","author":"Doi","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.04.008_bib0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ajcn\/61.3.585","article-title":"Effect of short-term ingestion of glucomannan on serum cholesterol in healthy men","volume":"61","author":"Arvill","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diacare.23.1.9","article-title":"Beneficial effects of viscous dietary fiber from konjac-mannan in subjects with the insulin resistance syndrome","volume":"23","author":"Vuksan","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2017.04.008_bib0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/07315724.2003.10719273","article-title":"Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects \u2212 a randomized double-blinded trial","volume":"22","author":"Chen","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0130","series-title":"Progress in Obesity Research 1990. Proceedings of the Sixth International Congress on Obesity","first-page":"507","article-title":"Metabolic and nutritional effects of long-term use of glucomannan in the treatment of obese diabetics","author":"Doi","year":"1990"},{"key":"10.1016\/j.phrs.2017.04.008_bib0135","first-page":"123","article-title":"Effect of konjac food on blood glucose level in patients with diabetes","volume":"3","author":"Huang","year":"1990","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.phrs.2017.04.008_bib0140","first-page":"S190","article-title":"Effects of konjac fiber (glucomannan) on glucose and lipids","volume":"49","author":"Doi","year":"1995","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0145","doi-asserted-by":"crossref","first-page":"370S","DOI":"10.1080\/07315724.2001.10719170","article-title":"Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus","volume":"20","author":"Vuksan","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ajcn\/57.6.868","article-title":"Meal-frequency effects on plasma hormone concentrations and cholesterol synthesis in human","volume":"57","author":"Jones","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0006-291X(73)91301-6","article-title":"Stimulation of insulin of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis activity","volume":"50","author":"Lakshmanan","year":"1973","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2017.04.008_bib0160","first-page":"1","article-title":"Effects of dietary fiber (glucomannan) on serum cholesterol","volume":"8","author":"Matsuura","year":"1986","journal-title":"Jpn. Soc. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.phrs.2017.04.008_bib0165","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/jn\/130.11.2753","article-title":"Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats","volume":"130","author":"Gallaher","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0170","first-page":"196","article-title":"The use of highly-purified glucomannan-based fibers in childhood obesity","volume":"14","author":"Livieri","year":"1992","journal-title":"Pediatr. Med. Chir."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.008_bib0175","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/88.4.1167","article-title":"Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis","volume":"88","author":"Sood","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/01.CIR.7.5.702","article-title":"Reduction of blood cholesterol in man","volume":"2","author":"Pollack","year":"1953","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.ejcn.1602765","article-title":"Food sources of plant sterols in the EPIC Norfolk population","volume":"62","author":"Klingberg","year":"2008","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.008_bib0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1079\/BJN20041234","article-title":"Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake","volume":"92","author":"Valsta","year":"2004","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.ejcn.1600559","article-title":"Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolemic and mildly hypercholesterolemic subjects","volume":"52","author":"Weststrate","year":"1998","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0200","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.ejcn.1601083","article-title":"Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low fat diet","volume":"54","author":"Hallikainen","year":"2000","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0205","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ajcn\/76.6.1272","article-title":"Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons","volume":"76","author":"Vanstone","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0210","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ajcn\/80.5.1159","article-title":"Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after 8 wk","volume":"80","author":"Varady","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2017.04.008_bib0215","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-2275(20)38403-0","article-title":"Inhibition of cholesterol absorption in rats by plant sterols","volume":"29","author":"Ikeda","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2017.04.008_bib0220","doi-asserted-by":"crossref","first-page":"G1009","DOI":"10.1152\/ajpgi.00446.2001","article-title":"Micellar distribution of cholesterol and phytosterols after duodenal plant sterol ester infusion","volume":"282","author":"Nissinen","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.008_bib0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ejcn.1602347","article-title":"Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes","volume":"60","author":"Yoshida","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2013.11.043","article-title":"European atherosclerosis society consensus panel on phytosterols","volume":"232","author":"Gylling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2017.04.008_bib0235","doi-asserted-by":"crossref","first-page":"591654","DOI":"10.1155\/2012\/591654","article-title":"Berberine in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2012","author":"Dong","year":"2012","journal-title":"Evid. Based Complement. Altern. Med"},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0240","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0032-1328321","article-title":"The effects of berberine on blood lipids: a systematic review and meta-analysis of randomized controlled trials","volume":"79","author":"Dong","year":"2013","journal-title":"Planta. Med."},{"key":"10.1016\/j.phrs.2017.04.008_bib0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipidemia, and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2017.04.008_bib0250","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/13543784.14.5.683","article-title":"Berberine a novel approach to cholesterol lowering","volume":"14","author":"Doggrell","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"30","key":"10.1016\/j.phrs.2017.04.008_bib0255","article-title":"Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level, and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial","volume":"14","author":"Cicero","year":"2015","journal-title":"Nutrition J."},{"issue":"7","key":"10.1016\/j.phrs.2017.04.008_bib0260","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejim.2014.06.008","article-title":"Nutraceuticals for the treatment of hypercholesterolemia","volume":"25","author":"Mannarino","year":"2014","journal-title":"Eur. J. Intern. Med."},{"issue":"November (1)","key":"10.1016\/j.phrs.2017.04.008_bib0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1749-8546-1-4","article-title":"Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials","volume":"23","author":"Liu","year":"2006","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0270","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rise results in significant LDL reduction but safety is uncertain \u2212 a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phanu.2013.02.003","article-title":"Nutraceutical combination (red yeast rise, berberine, and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients","volume":"1","author":"Pirro","year":"2013","journal-title":"PharmaNutrition"},{"issue":"August","key":"10.1016\/j.phrs.2017.04.008_bib0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.04.021","article-title":"The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Pirro","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0285","doi-asserted-by":"crossref","first-page":"23587","DOI":"10.1038\/srep23587","article-title":"Effects of a nutraceutical combination on lipids, inflammation, and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial","volume":"23","author":"Pirro","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2017.04.008_bib0290","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.04.008_bib0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000445359","article-title":"Middle-term dietary supplementation with red yeast rice plus coenzyme Q10 improves lipid pattern, endothelial reactivity, and arterial stiffness in moderately hypercholesterolemic subjects","volume":"68","author":"Cicero","year":"2016","journal-title":"Ann. Nutr. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0300","first-page":"593","article-title":"Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects","volume":"30","author":"Cicero","year":"2016","journal-title":"J. Biol. Regulators Homeostat. Agents"},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0305","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrcardio.2013.140-c1","article-title":"Curcuminoids for the management of hypertriglyceridaemia","volume":"11","author":"Sahebkar","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2017.04.008_bib0310","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ctim.2014.07.006","article-title":"Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial","volume":"22","author":"Panahi","year":"2014","journal-title":"Complement. Ther. Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.04.008_bib0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","article-title":"Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"68","author":"Panahi","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2017.04.008_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"linton, MF Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.phrs.2017.04.008_bib0325","article-title":"Curcumin: an effective adjunct in patients with statin-associated muscle symptoms","author":"Sahebkar","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0330","first-page":"1192","article-title":"Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Sahebkar","year":"2016","journal-title":"Pain Med."},{"key":"10.1016\/j.phrs.2017.04.008_bib0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","article-title":"Curcumin downregulates human tumor necrosis factor-\u03b1 levels: a systematic review and meta-analysis of randomized controlled trials","volume":"107","author":"Sahebkar","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2017.04.008_bib0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cytogfr.2016.10.001","article-title":"Curcumin as a natural regulator of monocyte chemoattractant protein-1","volume":"33","author":"Karimian","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2017.04.008_bib0345","article-title":"Curcumin: an effective inhibitor of interleukin-6","author":"Ghandadi","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2017.04.008_bib0350","doi-asserted-by":"crossref","DOI":"10.2174\/1381612823666170222122822","article-title":"Curcumin and endothelial function: evidence and mechanisms of protective effects","author":"Karimian","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2017.04.008_bib0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ecl.2008.11.011","article-title":"Other therapies for reducing low-density lipoprotein cholesterol: medications in development","volume":"38","author":"Stein","year":"2009","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.phrs.2017.04.008_bib0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jacl.2011.08.007","article-title":"Antisense therapy and emerging applications for the management of dyslipidemia","volume":"5","author":"Toth","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phrs.2017.04.008_bib0365","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","article-title":"Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein","volume":"114","author":"Kastelein","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40262-014-0224-4","article-title":"Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro\u00ae): a second-generation antisense oligonucleotide inhibitor of apolipoprotein","volume":"54","author":"Geary","year":"2015","journal-title":"B. Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2017.04.008_bib0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2017.04.008_bib0380","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/phar.1672","article-title":"Therapeutic management of familial hypercholesterolemia: current and emerging drug therapies","volume":"35","author":"Patel","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2017.04.008_bib0385","series-title":"Juxtapid (lomitapide) Package Insert","year":"2015"},{"issue":"10","key":"10.1016\/j.phrs.2017.04.008_bib0390","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.numecd.2016.05.006","article-title":"Proprotein convertase subtilisn\/kexin type 9 (PCSK9) inhibitors: present perspectives and future horizons","volume":"26","author":"Yadav","year":"2016","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2017.04.008_bib0395","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd3879","article-title":"Cholesterol-lowering blockbuster candidates speed into Phase III trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2017.04.008_bib0400","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOL.0b013e3283613a3d","article-title":"PCSK9 inhibitors","volume":"24","author":"Farnier","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0405","doi-asserted-by":"crossref","first-page":"641","DOI":"10.18553\/jmcp.2016.22.6.641","article-title":"A systematic review of PCSK9 inhibitors alirocumab and evolocumab","volume":"22","author":"McDonagh","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.phrs.2017.04.008_bib0410","series-title":"Praluent (alirocumab) Package Insert","year":"2015"},{"key":"10.1016\/j.phrs.2017.04.008_bib0415","series-title":"Repatha (evolocumab) Package Insert","year":"2015"},{"key":"10.1016\/j.phrs.2017.04.008_bib0420","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.jacc.2012.03.007","article-title":"Safety and efficacy of a monoclonal antibody to proprotein convertase subtilizing\/kexin type 9 serine protease, SAR236553\/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy","volume":"59","author":"McKenney","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"January (9911)","key":"10.1016\/j.phrs.2017.04.008_bib0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomized, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet"},{"issue":"April","key":"10.1016\/j.phrs.2017.04.008_bib0430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2016.01.036","article-title":"RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises apoA-I\/HDL, and represses pathways that contribute to cardiovascular disease","volume":"247","author":"Gilham","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.phrs.2017.04.008_bib0435","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOL.0000000000000332","article-title":"Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation","volume":"27","author":"Yamashita","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2017.04.008_bib0440","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1172\/JCI116750","article-title":"Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency","volume":"92","author":"Ikewaki","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2017.04.008_bib0445","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.04.008_bib0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1527-3466.2008.00049.x","article-title":"Viability of developing CETP inhibitors","volume":"26","author":"Sirtori","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2017.04.008_bib0455","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/f1000research.4396.1","article-title":"CETP inhibitors and cardiovascular disease: time to think again","volume":"3","author":"Miller","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2017.04.008_bib0460","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCULATIONAHA.115.014026","article-title":"Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP as a target to lower CVD risk: suspension of disbelief?","volume":"132","author":"Hovingh","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.04.008_bib0465","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOL.0b013e3283612454","article-title":"Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk? Curr","volume":"24","author":"Schaefer","year":"2013","journal-title":"Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.phrs.2017.04.008_bib0470","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/ejcn.2010.178","article-title":"Beta-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials","volume":"64","author":"AbuMweis","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0475","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jep.2010.01.021","article-title":"Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E","volume":"128","author":"Chua","year":"2010","journal-title":"Br. J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.008_bib0480","first-page":"179","article-title":"The effects of phytosterols\/stanols on blood lipid profiles: a systematic review with meta-analysis","volume":"18","author":"Wu","year":"2009","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2017.04.008_bib0485","doi-asserted-by":"crossref","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2017.04.008_bib0490","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clnu.2013.09.012","article-title":"A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels","volume":"33","author":"Sahebkar","year":"2014","journal-title":"Clin. Nutr."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181631430X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181631430X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T10:51:24Z","timestamp":1658919084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181631430X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":98,"alternative-id":["S104366181631430X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.04.008","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}